Clinical Trials in Pavia, Pavia
1 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD)Solid Organ Transplant ComplicationsLymphoproliferative Disorders+2 more
Pierre Fabre Medicament115 enrolled71 locationsNCT03394365
Recruiting
CDK4/6 Inhibitors in Breast Cancer Elderly Patients: an Observational Ambispective Longitudinal Multicenter Study
Breast CancerOld Age
Fondazione IRCCS Policlinico San Matteo di Pavia100 enrolled1 locationNCT07399808
Recruiting
A Master Protocol Empowering Mechanobiology Translation Research in Breast Cancer
Breast Cancer
IFOM ETS - The AIRC Institute of Molecular Oncology1,500 enrolled10 locationsNCT04625023
Recruiting
Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
Immune Checkpoint Inhibitors-induced ColitisAdvanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney AdenocarcinomaIleo-colitis+1 more
Fondazione IRCCS Policlinico San Matteo di Pavia250 enrolled1 locationNCT06899789
Recruiting
Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE VariaTionS
Mesothelioma, Malignant Pleural
Fondazione IRCCS Policlinico San Matteo di Pavia60 enrolled2 locationsNCT06886672